Detalles de la búsqueda
1.
The effect of neighborhood socioeconomic disadvantage on smoking status, quit attempts, and receipt of cessation support among adults with cancer: Results from nine ECOG-ACRIN Cancer Research Group trials.
Cancer
; 130(3): 439-452, 2024 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37795845
2.
A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG-ACRIN Cancer Research Group (EAQ152).
Cancer
; 128(7): 1381-1391, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34890045
3.
A phase II study of sapanisertib (TAK-228) a mTORC1/2 inhibitor in rapalog-resistant advanced pancreatic neuroendocrine tumors (PNET): ECOG-ACRIN EA2161.
Invest New Drugs
; 40(6): 1306-1314, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36264382
4.
Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis.
Lancet Oncol
; 22(5): 727-736, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33862002
5.
Tolerability of bevacizumab and chemotherapy in a phase 3 clinical trial with human epidermal growth factor receptor 2-negative breast cancer: A trajectory analysis of adverse events.
Cancer
; 127(24): 4546-4556, 2021 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34726788
6.
Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era.
Blood
; 129(13): 1763-1767, 2017 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-28082441
7.
Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups.
Blood
; 127(12): 1551-8, 2016 Mar 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-26755712
8.
Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590).
Cancer
; 123(23): 4653-4662, 2017 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28786105
9.
Working after a metastatic cancer diagnosis: Factors affecting employment in the metastatic setting from ECOG-ACRIN's Symptom Outcomes and Practice Patterns study.
Cancer
; 122(3): 438-46, 2016 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26687819
10.
Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic Leukemia.
Acta Haematol
; 136(4): 210-218, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27632567
11.
Comparison of the prognostic utility of the revised International Prognostic Scoring System and the French Prognostic Scoring System in azacitidine-treated patients with myelodysplastic syndromes.
Br J Haematol
; 166(3): 352-9, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24712482
12.
Platelet count doubling after the first cycle of azacitidine therapy predicts eventual response and survival in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukaemia but does not add to prognostic utility of the revised IPSS.
Br J Haematol
; 167(1): 62-8, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24995683
13.
Importance of Low- and Moderate-Grade Adverse Events in Patients' Treatment Experience and Treatment Discontinuation: An Analysis of the E1912 Trial.
J Clin Oncol
; 42(3): 266-272, 2024 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37801678
14.
Patient-Reported Adverse Events and Early Treatment Discontinuation Among Patients With Multiple Myeloma.
JAMA Netw Open
; 7(3): e243854, 2024 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38536173
15.
The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study.
Cancer
; 119(24): 4333-40, 2013 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24114037
16.
Cigarette and Alternative Tobacco Product Use among Adult Cancer Survivors Enrolled in 9 ECOG-ACRIN Clinical Trials.
Cancer Epidemiol Biomarkers Prev
; 32(11): 1552-1557, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37410096
17.
Examining allostatic load, neighborhood socioeconomic status, symptom burden and mortality in multiple myeloma patients.
Blood Cancer J
; 12(4): 53, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35365604
18.
CNS involvement in AML at diagnosis is rare and does not affect response or survival: data from 11 ECOG-ACRIN trials.
Blood Adv
; 5(22): 4560-4568, 2021 11 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34597373
19.
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group.
Radiother Oncol
; 156: 281-293, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33515668
20.
A phase II trial of triapine (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503.
Invest New Drugs
; 28(1): 91-7, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19238328